IMVIF

0.00010.00%
AH

Andrew Hall

CEO & Director

Mr. Andrew Hall, B. Med. Sci., M.Sc. serves as the Chief Executive Officer, Secretary & Board Member of Consano Bio, Inc. and serves as its Treasurer. He was Chief Executive Officer of IMV Inc. since December 2021. Mr. Hall served as an Interim Chief Executive Officer at IMV Inc. from August 4, 2021 to December 2021 and served its Chief Business Officer since November 09, 2020 until December 2021. He serves as Director of IMV Inc. since January 1, 2022. An accomplished business growth executive, Mr. Hall joins IMV with lots of executive experience in biopharmaceuticals and life sciences. He has spent his career focused on corporate and portfolio strategy, as well as business development and commercial operations with industry leaders such as Celgene, Merck, Schering-Plough and Bristol-Meyers Squibb spearheading new product development, analytics and commercial strategy for immunology & inflammation, oncology, women's health, cardiovascular portfolios and more. Mr. Hall was the Executive Director, Global Women Health for Merck. In his most recent roles with Celgene, Mr. Hall had led new product analytics and commercial strategy for the Inflammation & Immunology division and led new critical alliances across all therapeutic areas. He served as Executive Director, Business Development and Global Alliances (2017-2020) and Executive Director, Global Immunology, Commercial Strategy (2014-2017) at Celgene (2014-2020). Mr. Hall holds a Master of Science from RMIT University and a Bachelor of Medical Science with Honors from Melbourne University.

Positions